Dongho Song agreed to acquire G Biologics Co., Ltd. from PHARMA RESEARCH BIO Co., Ltd. (XKON:A217950) for KRW 5.2 billion on June 29, 2018. Dongho Song will pay the consideration in cash on June 29, 2018. PHARMA RESEARCH BIO Co., Ltd. will sell 0.2 million shares of G Biologics Co., Ltd. After the transaction, PHARMA RESEARCH BIO Co., Ltd. will not hold any stake in PHARMA RESEARCH BIO Co., Ltd. The Board of Director passed a resolution for the transaction on June 29, 2018. The transaction is expected to be completed on June 29, 2018. Hanmi Accounting Corporation acted as the external rating institution.